Lanreotide was given at a dosage of 60 mg (42%), 90 mg (33%) or 120 mg (25%). It was given at a 4 weekly interval in 75% of patients and at a 6 weekly interval in 17% of patients. One patient (8%) ...
The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS, Paris, France)—which does not require reconstitution before injection and is available in ready-to-use, prefilled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback